Skip to main content
An official website of the United States government

Funded Grants

PI Name Sort descending PI Organization Title Grant Number Program Official
Thompson, Patricia Ann

State University New York Stony Brook
United States

Three-Arm randomized trial comparing the effect of aspirin, sulindac or no treatment control on breast density in patients with elevated breast cancer risk 5R01CA235720-05 Edward Sauter, M.D., Ph.D.
Thompson, Patricia Ann

University Of Arizona
United States

University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet) 5UG1CA242596-06 Donald Johnsey
Tighiouart, Mourad

Cedars-Sinai Medical Center
United States

Advancing Analysis and Interpretation of Adverse Events and PROs in Cancer Clinical Trials 3U01CA232859-05S1 Rachel Altshuler, Ph.D.
Tollefsbol, Trygve O

University Of Alabama At Birmingham
United States

Combinatorial epigenetic-based prevention of breast cancer 5R01CA178441-10 Gabriela Riscuta, M.D., CNS
Tong, Frank

Vanderbilt University
United States

Learning the visual and cognitive bases of lung nodule detection 5R01CA240274-05 Richard Mazurchuk, Ph.D.
Toriola, Adetunji T

Washington University
United States

Targeting RANK Pathway in Mammographic Density and Primary Breast Cancer Prevention 4R37CA235602-06 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Torres, Keila Enitt

University Of Tx Md Anderson Can Ctr
United States

Use of Noninvasive Biomarkers and Advanced MRI for early detection of NF1-associated MPNSTs 5R01CA285980-02 Guillermo Marquez, Ph.D.
Tussing-Humphreys, Lisa

University Of Illinois At Chicago
United States

Effects of Time-restricted Eating versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers among Adults with Obesity 3R01CA257807-04S1 Nancy J. Emenaker, Ph.D., RDN, LD, FAND
Ulrich, Cornelia M

University Of Utah
United States

Adipose tissue-colorectal tumor cross-talk: new targets for breaking the obesity-cancer link 5R01CA254108-04 Asad Umar, D.V.M., Ph.D.
V, DHODAPKAR, MADHAV

EMORY UNIVERSITY
United States

Targeting microbial triggers of gammopathy for immunoprevention 1UG3CA290302-01